Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
GSK-3β inhibitor suppresses symptom onset and progression of ALS model mice
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 김승현 | - |
| dc.date.accessioned | 2021-08-04T02:51:24Z | - |
| dc.date.available | 2021-08-04T02:51:24Z | - |
| dc.date.issued | 2006-07-02 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/69766 | - |
| dc.description.abstract | : Glycogen synthase kinase (GSK)-3β has recently been emphasized as an important pathogenic mechanism in neurodegenerative diseases. Although the neuroprotective effects of GSK-3β inhibitors in Alzheimer`s disease have been demonstrated | - |
| dc.title | GSK-3β inhibitor suppresses symptom onset and progression of ALS model mice | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | 11th international congress on neuromuscular diseases | - |
| dc.citation.conferencePlace | 이스탄불, 터키 | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 신경과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Kim, Seung Hyun
- 서울 의과대학 (DEPARTMENT OF NEUROLOGY)